SNP 6.0 array-based uniquely detectable lesions and survival in AML (univariate analysis)
| Genomic lesions only detected by SNP 6.0 array profiling . | Survival (median, d) . | Hazard ratio . | CI . | P . |
|---|---|---|---|---|
| All-treatment group | ||||
| 0 vs ≥ 1 | 568/250 | 2.08 | 1.3-3.32 | .002 |
| ≤ 1 vs ≥ 2 | 744/133 | 3.36 | 2.08-5.44 | < .001 |
| ≤ 2 vs ≥ 3 | 520/122 | 4.31 | 2.47-7.5 | < .001 |
| ≤ 3 vs ≥ 3 | 472/122 | 3.88 | 2.2-6.83 | < .001 |
| ≤ 4 vs ≥ 4 | 433/104 | 4.31 | 2.39-7.8 | < .001 |
| ≤ 5 vs ≥ 5 | 433/104 | 4.31 | 2.39-7.8 | < .001 |
| ≤ 9 vs ≥ 10 | 421/109 | 3.86 | 2.07-7.21 | < .001 |
| Intensive-treatment group | ||||
| 0 vs ≥ 1 | 826/284 | 1.92 | 1.15-3.21 | .01 |
| ≤ 1 vs ≥ 2 | 795/169 | 3.01 | 1.76-5.14 | < .001 |
| ≤ 2 vs ≥ 3 | 520/122 | 3.85 | 1.99-7.43 | < .001 |
| ≤ 3 vs ≥ 3 | 520/109 | 3.7 | 1.89-7.25 | < .001 |
| ≤ 4 vs ≥ 4 | 520/104 | 4.11 | 2.04-8.28 | < .001 |
| ≤ 5 vs ≥ 5 | 520/104 | 4.11 | 2.04-8.28 | < .001 |
| ≤ 9 vs ≥ 10 | 472/109 | 3.76 | 1.83-7.75 | < .001 |
| Genomic lesions only detected by SNP 6.0 array profiling . | Survival (median, d) . | Hazard ratio . | CI . | P . |
|---|---|---|---|---|
| All-treatment group | ||||
| 0 vs ≥ 1 | 568/250 | 2.08 | 1.3-3.32 | .002 |
| ≤ 1 vs ≥ 2 | 744/133 | 3.36 | 2.08-5.44 | < .001 |
| ≤ 2 vs ≥ 3 | 520/122 | 4.31 | 2.47-7.5 | < .001 |
| ≤ 3 vs ≥ 3 | 472/122 | 3.88 | 2.2-6.83 | < .001 |
| ≤ 4 vs ≥ 4 | 433/104 | 4.31 | 2.39-7.8 | < .001 |
| ≤ 5 vs ≥ 5 | 433/104 | 4.31 | 2.39-7.8 | < .001 |
| ≤ 9 vs ≥ 10 | 421/109 | 3.86 | 2.07-7.21 | < .001 |
| Intensive-treatment group | ||||
| 0 vs ≥ 1 | 826/284 | 1.92 | 1.15-3.21 | .01 |
| ≤ 1 vs ≥ 2 | 795/169 | 3.01 | 1.76-5.14 | < .001 |
| ≤ 2 vs ≥ 3 | 520/122 | 3.85 | 1.99-7.43 | < .001 |
| ≤ 3 vs ≥ 3 | 520/109 | 3.7 | 1.89-7.25 | < .001 |
| ≤ 4 vs ≥ 4 | 520/104 | 4.11 | 2.04-8.28 | < .001 |
| ≤ 5 vs ≥ 5 | 520/104 | 4.11 | 2.04-8.28 | < .001 |
| ≤ 9 vs ≥ 10 | 472/109 | 3.76 | 1.83-7.75 | < .001 |